US OptionsDetailed Quotes
OTLK250117C12500
- 0.05
- 0.000.00%
15min DelayClose Jan 3 16:00 ET
0.05High0.05Low
0.05Open0.05Pre Close39 Volume14 Open Interest12.50Strike Price195.00Turnover499.58%IV460.27%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier12DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0752Delta0.0697Gamma44.80Leverage Ratio-0.0114Theta0.0000Rho3.37Eff Leverage0.0006Vega
Outlook Therapeutics Stock Discussion
Sign in to post a comment
$Outlook Therapeutics (OTLK.US)$ Reuters
1 min ago
Outlook Therapeutics Inc - First Positive Reimbursement Decision Worldwide for Lytenava™; First Launch Anticipated in H1 2025
1 min ago
Outlook Therapeutics Inc - First Positive Reimbursement Decision Worldwide for Lytenava™; First Launch Anticipated in H1 2025
6
$Outlook Therapeutics (OTLK.US)$ $3 tonight. A retest at $2.4 yesterday.
4
$Outlook Therapeutics (OTLK.US)$ 👀potential overnight play of today but I don’t like going long in red day
$Outlook Therapeutics (OTLK.US)$
this company very strong support company. until weight January you can get $5
this company very strong support company. until weight January you can get $5
2
1
$Outlook Therapeutics (OTLK.US)$ agen will be come back 5 Dollars
2
1
$Outlook Therapeutics (OTLK.US)$ Next week 2.5-3.0, holding till Jan 2025 where they will release 3 month efficacy report.
3
No comment yet
carlton griffiths OP : despite the losses